Rocket Pharmaceuticals, Inc. Realized Investment Gains (Losses)
Rocket Pharmaceuticals, Inc. (RCKT) reported Realized Investment Gains (Losses) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2026-02-26
- Rocket Pharmaceuticals, Inc. realized investment gains (losses) for the quarter ending 2018-12-31 was $0.00.
- Rocket Pharmaceuticals, Inc. realized investment gains (losses) for the quarter ending 2018-09-30 was $0.00.
- Rocket Pharmaceuticals, Inc. realized investment gains (losses) for the quarter ending 2018-06-30 was $0.00.
- Rocket Pharmaceuticals, Inc. realized investment gains (losses) for the quarter ending 2018-03-31 was $0.00.
- Rocket Pharmaceuticals, Inc. realized investment gains (losses) for fiscal 2025 was $0.00.
- Rocket Pharmaceuticals, Inc. realized investment gains (losses) for fiscal 2024 was $0.00.
- Rocket Pharmaceuticals, Inc. realized investment gains (losses) for fiscal 2023 was $0.00.
- Rocket Pharmaceuticals, Inc. realized investment gains (losses) for fiscal 2022 was $0.00.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | $0.00 derived: sum of 4 quarters · filed 2019-03-08 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 derived: sum of 4 quarters · filed 2019-03-08 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 10-K · filed 2019-03-08 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | $0.00 derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 10-K · filed 2019-03-08 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | $0.00 derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2017-08-03 | $0.00 derived: sum of 4 quarters · filed 2017-08-03 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-05-10 | $0.00 derived: sum of 3 quarters · filed 2017-05-10 | $0.00 derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-10 | $0.00 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |